Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) as an add-on Treatment for Resistant Obsessive-compulsive Symptoms in Patients With Schizophrenia [NA]
A clinical trial update announcing completion of a study evaluating repetitive transcranial magnetic stimulation as an add-on treatment for …
-
CLINICAL_TRIALS research · 2016-02-29Clinical Trial Update: Application of Vagal Stimulation in Exposure and Response Prevention for Obsessive Compulsive Disorder [NA]
This clinical trial update describes a study at King's College London evaluating vagal stimulation as an adjunct to exposure and response pr…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Rechargeable Neurostimulators in Deep Brain Stimulation for Psychiatric Disorders [NA]
A completed clinical trial evaluated rechargeable neurostimulators used in deep brain stimulation. The study targeted obsessive-compulsive d…
-
CLINICAL_TRIALS research · 2016-02-03Clinical Trial Update: Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders [NA]
The study completed a web-based training program for therapists delivering cognitive behavioral therapy for anxiety disorders, including obs…
-
FDA approval · 2016-01-12FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine from Alembic Pharmaceuticals Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2016-01-10FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc. to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD) [NA]
This completed clinical trial evaluated the effectiveness and neuropsychological predictors of guided self-help for Obsessive-Compulsive Dis…
-
FDA approval · 2015-12-23FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for sertraline hydrochloride (Lupin Pharmaceuticals, Inc.), a generic product under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: rTMS in Treatment of Obsessive Compulsive Disorder (OCD) [NA]
A completed clinical trial studying repetitive transcranial magnetic stimulation as a treatment for Obsessive-Compulsive Disorder, sponsored…
-
FDA approval · 2015-11-24FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Deep Brain Stimulation of NAc/ALIC to Prevent Treatment-Refractory Obsessive Compulsive Disorder [NA]
Clinical trial update on deep brain stimulation of the nucleus accumbens and anterior limb of the internal capsule to prevent treatment-refr…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder [Phase 4]
Phase 4 trial evaluating methylphenidate hydrochloride extended-release tablets as augmentation therapy in obsessive-compulsive disorder; th…
-
FDA approval · 2015-09-16FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for fluvoxamine maleate (generic) from Endo USA, Inc. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation in the Treatment of Obsessive Compulsive Disorders [NA]
A completed clinical trial evaluated repetitive transcranial magnetic stimulation as a treatment for obsessive-compulsive disorders.
-
FDA approval · 2015-07-28FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for fluvoxamine maleate by Apotex Corp. This approval confirms the continued availability of a gener…
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Exercise and Health Intervention for Patients With Obsessive Compulsive Disorder (OCD) [Phase 2]
Phase 2 clinical trial evaluating an exercise and health intervention for patients with Obsessive Compulsive Disorder has completed; results…
-
FDA approval · 2015-06-09FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for sertraline hydrochloride (generic) from Quallent Pharmaceuticals Health LLC under ANDA077397.
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder [Phase 2]
A Phase 2 trial evaluated videophone-delivered cognitive-behavioral therapy for children with Obsessive-Compulsive Disorder; results were po…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Efficacy and Adverse Events of Bilateral Single-shot VC/VS Gamma Capsulotomy for OCD: a Pilot Study [Phase 2]
Phase 2 pilot study evaluating the efficacy and safety of bilateral single-shot VC/VS gamma capsulotomy for obsessive-compulsive disorder. T…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Safety and Effectiveness of Capsulotomy in Refractory OCD [Phase 2, Phase 3]
Clinical trial update reporting on the safety and effectiveness of capsulotomy for refractory obsessive-compulsive disorder across Phase 2 a…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Antidepressant Safety in Kids Study
A completed clinical trial update focusing on the safety of antidepressants in children. The study included conditions such as anxiety disor…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism [NA]
A completed clinical trial evaluated cognitive behavioral therapy for anxiety disorders in adolescents with autism, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: "Association Splitting" in Obsessive-Compulsive Disorder (OCD) [NA]
A completed clinical trial at Universitätsklinikum Hamburg-Eppendorf evaluated the concept of 'association splitting' in obsessive-compulsiv…
-
FDA approval · 2015-03-16FDA Approved: FLUOXETINE — Original Application (Vensun Pharmaceuticals, Inc.)
The FDA approved Vensun Pharmaceuticals' original (ANDA) application for fluoxetine hydrochloride, establishing a generic fluoxetine product…
-
FDA approval · 2015-01-12FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for a generic fluoxetine product (ANDA 076458) from Chartwell Governmental & Specialty RX, LLC. This…